1.1 Articolo in rivista

1.1 Articolo in rivista: [9362] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 341 a 360 di 9.362

Treatment of Stage III-IV Non-Small-Cell Lung Carcinoma with Vinorelbine in Combination with Ifosfamide plus MESNA: A Study by the Southern Italy Oncology Group (GOIM)

1996-01-01 Gebbia, Vittorio; Galetta, Domenico; Majello, Evaristo; Valenza, Roberto; Colucci, Giuseppe; Gebbia, Nicolò

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

1996-01-01 Gebbia, V; Testa, A; Gebbia, N.

Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma

1996-01-01 Gebbia, Vittorio; Testa, Antonio; Majello, Evaristo; Cannata, Giuseppe; Lina Tirrito, Maria; Mastrandrea, Giuseppe; Feo, Mario; Bajardi, Guido; Colucci, Giuseppe; Gebbia, Nicol??

Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)

1996-01-01 Colucci, G; Maiello, E; Gebbia, V; Cifarelli, Ra; Biglietto, M; Pedicini, A; Durini, E; Giuliani, F; Gebbia, N.

Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: A pilot study

1996-01-01 Gebbia, V.; Testa, A.; Cannata, G.; Gebbia, N.

Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients

1996-01-01 Maiello, E.; Giotta, F.; Gebbia, V.; Testa, A.; Galetta, D.; Riccardi, F.; Gebbia, N.; Colucci, G.

Single agent paclitaxel in advanced squamous cell head and neck carcinoma

1996-01-01 Gebbia, V; Testa, A; Cannata, G; Gebbia, N.

Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer

1996-01-01 Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Astara, G; Lampis, B; Dessi, D; Santona, M; Massa, E

Second line chemotherapy for metastatic colorectal carcinoma: A phase II study with mitomycin C, adriamycin and lonidamine

1996-01-01 Gebbia, V.; Testa, A.; Cannata, G.; Tirrito, M. L.; Longo, A.; Sciume, C.; Valdesi, M.; Salamone, G.; Gebbia, N.; Leo, P.

Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)

1996-01-01 Gebbia, V; Majello, E; Testa, A; Pezzella, G; Giuseppe, S; Giotta, F; Riccardi, F; Fortunato, S; Colucci, G; Gebbia, N.

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)

1996-01-01 Gridelli, C; Perrone, F; Palmeri, S; D'Aprile, M; Cognetti, F; Rossi, A; Gebbia, V; Pepe, R; Veltri, E; Airoma, G; Russo, A; Incoronato, P; Scinto, Af; Palazzolo, G; Natali, M; Leonardi, V; Gallo, C; De Placido, S; Bianco, Ar.

Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma

1996-01-01 Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Massa, E; Astara, G; Lampis, B; Dessi, D; Santona, M

Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma

1996-01-01 Bajetta, E; Di Bartolomeo, M; Somma, L; Moreschi, M; Comella, G; Turci, D; Gebbia, V; Scanni, A; Bordogna, G; Stampino, Cg.

Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer

1994-01-01 Gebbia, V; Valenza, R; Testa, A; Cannata, G; Verderame, F; Gebbia, N.

Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)

1997-01-01 Colucci, G; Gebbia, V; Galetta, D; Riccardi, F; Cariello, S; Gebbia, N.

Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group

1997-01-01 Colucci, G.; Giotta, F.; Gebbia, V.; Riccardi, F.; Pezzella, G.; Durini, E.; Caruso, M.; Romito, S.; Gebbia, N.

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study

1997-01-01 Gebbia, V; Mantovani, G; Farris, A; Agostara, B; Desogus, A; Curreli, L; Moschella, F; Di Gregorio, C; Bajetta, E; Gebbia, N

Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer

1997-01-01 Gebbia, Vittorio; Borsellino, Nicolò; Testa, Antonio; Latteri, Mario Adelfio; Milia, Valerio; Valdesi, Matteo; Giotta, Francesco; Gebbia, Nicolò; Colucci, Giuseppe

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.

1998-01-01 Bajetta, E; Di Bartolomeo, M; Carnaghi, C; Buzzoni, R; Mariani, L; Gebbia, V; Comella, G; Pinotti, G; Ianniello, G; Schieppati, G; Bochicchio, Am; Maiorino, L.

Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma

1998-01-01 Naglieri, E; Gebbia, V; Durini, E; Lelli, G; Abbate, I; Selvaggi, Fp; Di Tonno, P; Colucci, G.

Titolo	Data di pubblicazione	Autore(i)
Treatment of Stage III-IV Non-Small-Cell Lung Carcinoma with Vinorelbine in Combination with Ifosfamide plus MESNA: A Study by the Southern Italy Oncology Group (GOIM)	1-gen-1996	Gebbia, Vittorio; Galetta, Domenico; Majello, Evaristo; Valenza, Roberto; Colucci, Giuseppe; Gebbia, Nicolò
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer	1-gen-1996	Gebbia, V; Testa, A; Gebbia, N.
Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma	1-gen-1996	Gebbia, Vittorio; Testa, Antonio; Majello, Evaristo; Cannata, Giuseppe; Lina Tirrito, Maria; Mastrandrea, Giuseppe; Feo, Mario; Bajardi, Guido; Colucci, Giuseppe; Gebbia, Nicol??
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)	1-gen-1996	Colucci, G; Maiello, E; Gebbia, V; Cifarelli, Ra; Biglietto, M; Pedicini, A; Durini, E; Giuliani, F; Gebbia, N.
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: A pilot study	1-gen-1996	Gebbia, V.; Testa, A.; Cannata, G.; Gebbia, N.
Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients	1-gen-1996	Maiello, E.; Giotta, F.; Gebbia, V.; Testa, A.; Galetta, D.; Riccardi, F.; Gebbia, N.; Colucci, G.
Single agent paclitaxel in advanced squamous cell head and neck carcinoma	1-gen-1996	Gebbia, V; Testa, A; Cannata, G; Gebbia, N.
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer	1-gen-1996	Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Astara, G; Lampis, B; Dessi, D; Santona, M; Massa, E
Second line chemotherapy for metastatic colorectal carcinoma: A phase II study with mitomycin C, adriamycin and lonidamine	1-gen-1996	Gebbia, V.; Testa, A.; Cannata, G.; Tirrito, M. L.; Longo, A.; Sciume, C.; Valdesi, M.; Salamone, G.; Gebbia, N.; Leo, P.
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)	1-gen-1996	Gebbia, V; Majello, E; Testa, A; Pezzella, G; Giuseppe, S; Giotta, F; Riccardi, F; Fortunato, S; Colucci, G; Gebbia, N.
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)	1-gen-1996	Gridelli, C; Perrone, F; Palmeri, S; D'Aprile, M; Cognetti, F; Rossi, A; Gebbia, V; Pepe, R; Veltri, E; Airoma, G; Russo, A; Incoronato, P; Scinto, Af; Palazzolo, G; Natali, M; Leonardi, V; Gallo, C; De Placido, S; Bianco, Ar.
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma	1-gen-1996	Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Massa, E; Astara, G; Lampis, B; Dessi, D; Santona, M
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma	1-gen-1996	Bajetta, E; Di Bartolomeo, M; Somma, L; Moreschi, M; Comella, G; Turci, D; Gebbia, V; Scanni, A; Bordogna, G; Stampino, Cg.
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer	1-gen-1994	Gebbia, V; Valenza, R; Testa, A; Cannata, G; Verderame, F; Gebbia, N.
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)	1-gen-1997	Colucci, G; Gebbia, V; Galetta, D; Riccardi, F; Cariello, S; Gebbia, N.
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group	1-gen-1997	Colucci, G.; Giotta, F.; Gebbia, V.; Riccardi, F.; Pezzella, G.; Durini, E.; Caruso, M.; Romito, S.; Gebbia, N.
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study	1-gen-1997	Gebbia, V; Mantovani, G; Farris, A; Agostara, B; Desogus, A; Curreli, L; Moschella, F; Di Gregorio, C; Bajetta, E; Gebbia, N
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer	1-gen-1997	Gebbia, Vittorio; Borsellino, Nicolò; Testa, Antonio; Latteri, Mario Adelfio; Milia, Valerio; Valdesi, Matteo; Giotta, Francesco; Gebbia, Nicolò; Colucci, Giuseppe
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.	1-gen-1998	Bajetta, E; Di Bartolomeo, M; Carnaghi, C; Buzzoni, R; Mariani, L; Gebbia, V; Comella, G; Pinotti, G; Ianniello, G; Schieppati, G; Bochicchio, Am; Maiorino, L.
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma	1-gen-1998	Naglieri, E; Gebbia, V; Durini, E; Lelli, G; Abbate, I; Selvaggi, Fp; Di Tonno, P; Colucci, G.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 341 a 360 di 9.362

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext9361